Skip to main content
All lobbying filings

National Kidney Foundation

National Kidney Foundation filed a Q4 report for National Kidney Foundation on January 20, 2026.

Lobbying for National Kidney Foundation

As filed: NATIONAL KIDNEY FOUNDATION for NATIONAL KIDNEY FOUNDATION.

All filings by National Kidney Foundation · Everything National Kidney Foundation has reported

 Filing · LD-2 quarterly report Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 20, 2026
Expenses
$60,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
New York

Official filing document

 Lobbying activity 3

FY 2026 Appropriations for organ donation and transplantation activities (HRSA). FY 2026 Appropriations for CDC, including the Chronic Kidney Disease Initiative. FY 2026 Appropriations for kidney research at the National Institute of Diabetes and Digestive and Kidney Diseases. FY 2026 Appropriations for Dept. of Defense Congressionally Directed Medical Research Program. FY 2026 Appropriations for Indian Health Service.

Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Request to require inclusion of phosphorus on nutrition labels. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.

Initiatives to expand access to home dialysis. Request to Reinstate Race & Ethnicity Data Collection in the ESRD Quality Reporting System. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.

 Bills named in this filing 10
  • H.R. 628
    Honor Our Living Donors Act
  • S. 957
    Honor Our Living Donors Act
  • S. 1552
    Living Donor Protection Act of 2025
  • H.R. 4583
    Living Donor Protection Act of 2025
  • H.R. 4582
    To amend the Family and Medical Leave Act of 1993 and title 5, United States Code, to clarify that organ donation surge…
  • H.R. 1518
    New Era of Preventing End-Stage Kidney Disease Act
  • S. 1973
    Treat and Reduce Obesity Act of 2025
  • H.R. 4231
    Treat and Reduce Obesity Act of 2025
  • S. 1261
    CONNECT for Health Act of 2025
  • H.R. 4206
    CONNECT for Health Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem